Welcome to Diavantis

Diavantis is a young and aspiring medical technology start-up with a small but very interdisciplinary team located in Switzerland. The company’s focus lies on the development and marketing of vascular accesses for haemodialysis. We are a spin-off fully owned by Cendres+Métaux SA, one of the leading Swiss companies in the field of medical technology.

Our current investigational device, Vivaxs Liva, is a port system which consists of a titanium implant, a replaceable cover and a catheter. The novelty lies in its fixation to the head, for which the team won the Swiss Technology Award 2014 in the category "Sustainability Leader".

At present, we are running an international multicentre clinical investigation under the name of “Bone Anchored Port - A novel access for haemodialysis” which started at the University Hospital in Berne.

Diavantis’ pipeline promises to improve patients’ quality of life and to create value for all stakeholders along the continuum of care.

Vivaxs Liva

Learn more about the investigational device Vivaxs Liva - the first bone anchored long-term vascular access for haemodialysis.

Clinical Trial

Find out more about the clinical investigation "Bone Anchored Port - A novel access for haemodialysis".

About Us

Meet the Diavantis team and learn more about our background, our mission and vision for the future of haemodialysis.